AstraZeneca Pulls Plug On Ionis’ PCSK9 Candidate

AstraZeneca will not move Ionis PCSK9 candidate ION449 into Phase III after Phase IIb results did not meet its high efficacy bar • Source: Shutterstock

More from Clinical Trials

More from R&D